JUNSHI BIO Appoints Chen Liang as Independent Non-Executive Director

Stock News
06/26

JUNSHI BIO (ASX: 01877) has announced that the resolution regarding the election of Mr. Chen Liang as an independent non-executive director was approved at the Annual General Meeting held on June 26, 2026.

His appointment as an independent non-executive director became effective on the date of the AGM, June 26, 2026.

Effective from the same date, Mr. Li Zhongxian was appointed as Chairman of the Audit Committee and the Remuneration and Appraisal Committee, as well as a member of the Strategy and ESG Committee.

Mr. Chen Liang was appointed as a member of the Audit Committee and the Compliance Committee.

The terms of these appointments are effective from the date of the shareholders' meeting approval, June 26, 2026, and will last until the conclusion of the fourth board of directors' term.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10